US › Healthcare

Procept Biorobotics Corp (PRCT)

US · Healthcare · Medical Devices

$18.28-0.54%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$83.1M
Revenue YoY
+20.2%
Net profit
$-31.6M
Profit YoY
-27.9%
EPS
$-0.56
EPS estimate
$-0.56
Net margin
-38.1%

EPS came in at -0.56 against a street estimate of -0.56 — a beat of 0.0%.

Key statistics

Market cap
$1.05B
Forward P/E
0.0
P/B
3.05
Book value
$6.11
EPS (TTM)
$-1.83
52-week high
$47.97
52-week low
$16.66
50-day MA
$22.68
200-day MA
$27.54
Beta
0.89

Analyst view

Analysts rate Procept Biorobotics Corp a buy (7 buy, 4 hold, 1 sell out of 12) with an average price target of $28.45.

Shareholding

Insiders
3.17%
Institutions
102.34%

Largest institutional holders

FundStake
BlackRock Inc7.66%
T. Rowe Price Investment Management,Inc.5.75%
BNP Paribas Investment Partners SA5.43%
Vanguard Portfolio Management, LLC4.25%
Vanguard Capital Management, LLC4.21%
Chicago Capital LLC3.64%
Prosight Management, LP3.42%
Mackenzie Investments3.02%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Procept Biorobotics Corp — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.